Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer’s disease-Reference-Cited by-同舟云学术

Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer’s disease

Published:2017-02-04 Issue:4 Volume:140 Page:1117-1127
ISSN:0006-8950
Container-title:Brain
language:en
Short-container-title:

Author:

Reeves Suzanne,McLachlan Emma,Bertrand Julie,D’Antonio Fabrizia,Brownings Stuart,Nair Akshay,Greaves Suki,Smith Alan,Taylor David,Dunn Joel,Marsden Paul,Kessler Robert,Howard Robert

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/140/4/1117/18244848/aww359.pdf

Reference62 articles.

1. A framework for quantifying the influence of adherence and dose individualization;Clin Pharmacol Ther,2016

2. Sex, race, and smoking impact olanzapine exposure;J Clin Pharmacol,2008

3. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories;Annu Rev Pharmacol Toxicol,2012

4. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? An in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients;Am J Psychiatry,2003

5. Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer’s disease, with [18F]fallypride positron emission tomography;Int J Geriatr Psychiatry,2014

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impairment of hippocampal astrocyte-mediated striatal dopamine release and locomotion in Alzheimer's disease;NeuroImage;2024-09

2. Neuropsychiatric Manifestations in Alzheimer’s Disease Patients: Genetics and Treatment Options;CNS & Neurological Disorders - Drug Targets;2024-01

3. Impairment of hippocampal astrocyte-mediated striatal dopamine release and locomotion in Alzheimer’s disease;2023-10-30

4. Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer’s disease;PLOS ONE;2023-10-24

5. The Impact of Muscarinic Antagonism on Psychosis-Relevant Behaviors and Striatal [11C] Raclopride Binding in Tau Mouse Models of Alzheimer’s Disease;Biomedicines;2023-07-25